 Inhibikase Therapeutics, Inc. NASDAQ:IKT Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET Company Participants Alex Lobo - Stern Investor Relations Milton Werner - Chief Executive Officer Joseph Frattaroli - Chief Financial Officer Conference Call Participants Operator Greetings, welcome to Inhibikase Therapeutics First Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. 